A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra.
暂无分享,去创建一个
Johan A Westerhuis | Doris M Jacobs | Jacques Vervoort | John van Duynhoven | Albert A de Graaf | A. Smilde | A. D. de Graaf | J. Westerhuis | J. Vervoort | D. Jacobs | J. V. van Duynhoven | V. Mihaleva | Velitchka V Mihaleva | Daniël B van Schalkwijk | Ferdinand A van Dorsten | Age Smilde | F. V. van Dorsten | D. V. van Schalkwijk
[1] Francesco Savorani,et al. NMR and interval PLS as reliable methods for determination of cholesterol in rodent lipoprotein fractions , 2010, Metabolomics.
[2] Ken Williams,et al. Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study , 2005, Circulation.
[3] S. Yamashita,et al. Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[4] Søren Balling Engelsen,et al. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models. , 2005, Clinical chemistry.
[5] L. Groop,et al. Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. , 1996, Journal of lipid research.
[6] D W Bennett,et al. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. , 1991, Clinical chemistry.
[7] J. Otvos,et al. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.
[8] J. Saltevo,et al. High serum adiponectin is associated with favorable lipoprotein subclass profile in 6.4-year follow-up. , 2011, European journal of endocrinology.
[9] L. A. Stone,et al. Computer Aided Design of Experiments , 1969 .
[10] R. Krauss,et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.
[11] Reino Laatikainen,et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.
[12] Kimmo Kaski,et al. The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent. , 2007, Atherosclerosis.
[13] T. Bathen,et al. Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis , 2000, NMR in biomedicine.
[14] M. Ala-Korpela. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool , 2007, Expert review of molecular diagnostics.
[15] Donald A. Smith,et al. Advanced lipoprotein testing: recommendations based on current evidence. , 2009, Endocrinology and metabolism clinics of North America.
[16] P. Barter,et al. Precursor-product relationship between pools of very low density lipoprotein triglyceride. , 1972, The Journal of clinical investigation.
[17] D. Bilheimer,et al. On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. , 1973, Biochimica et biophysica acta.
[18] A. Astrup,et al. High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics , 2010, Nutrition & metabolism.
[19] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[20] Olav M. Kvalheim,et al. Interpretation of partial least squares regression models by means of target projection and selectivity ratio plots , 2010 .
[21] Aki Vehtari,et al. A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data , 2007, BMC Bioinformatics.
[22] Rasmus Bro,et al. Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics , 2005 .
[23] G. Morris,et al. Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy , 2012, Analytical and Bioanalytical Chemistry.
[24] C. Packard,et al. Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias. , 2008, Atherosclerosis.